GBT is now part of Pfizer, and we look forward to continuing our mission and driving innovation to bring multiple potential best-in-class treatments to people living with #SickleCell disease. The Global Blood Therapeutics page will no longer be active or monitored. Please follow Pfizer for new content! We are so grateful for our employees and their work over these past 11 years to help people living with #SickleCell disease. GBT joining Pfizer is an exciting milestone that elevates the needs of the underserved sickle cell community and enables us to accelerate our mission. We’re thankful for all the accomplishments of members of our stellar team, past and present, and we’re proud of the impact we’ve made for the sickle cell community. Our commitment continues and is stronger than ever.
Global Blood Therapeutics
Biotechnology Research
South San Francisco, California 21,137 followers
About us
Global Blood Therapeutics (GBT) is now part of Pfizer, and we look forward to continuing our mission on behalf of people living with sickle cell disease. The Global Blood Therapeutics page will no longer be active or monitored. Please follow Pfizer for new content.
- Website
-
http://www.gbt.com
External link for Global Blood Therapeutics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2011
Locations
-
Primary
Get directions
181 Oyster Point Blvd
South San Francisco, California 94080, US